Rh Antibody Formation: Mechanisms in Rh-Negative Individuals

Rh antibodies (anti-D) form when Rh-negative individuals encounter Rh-positive red cells. Four main sensitization routes:

1. Transfusion

Rh-negative recipient receives Rh-positive RBCs (error or emergency uncrossmatched). Risk: ~20–30% develop anti-D without prophylaxis.

2. Pregnancy (Fetomaternal Hemorrhage)

• Antepartum: Silent FMH (trauma, procedures, abruption).
• Delivery: ~15–50% have FMH > 0.1 mL; 1% > 30 mL.
• Anti-D crosses placenta → hemolytic disease of fetus/newborn (HDFN).

3. Organ Transplantation

Rh-negative recipient of Rh-positive solid organ (kidney, liver, heart). Passenger lymphocytes produce D antigen → recipient sensitization. May cause passenger lymphocyte syndrome (hemolysis).

4. Blood Products

• Platelets: May contain residual RBCs (< 2 mL/apheresis unit).
• Plasma/IVIG: No RBCs; no Rh risk.

Prevention

• RhIg (RhoGAM): 300 µg IM at 28 weeks, within 72 hrs post-delivery (if infant Rh+), post-abortion, post-invasive procedures, post-transfusion of Rh+ platelets.
• Transfusion Policy: Rh-negative females < 50 receive Rh-negative RBCs/platelets when possible.

Clinical Significance

Anti-D is the most immunogenic non-ABO antibody. Once formed, it persists for life. Subsequent Rh+ exposure → anamnestic response → severe hemolysis (transfusion) or HDFN (pregnancy).